Navigation Links
Breast Cancer Diagnostic and Drug Technologies: Global Markets
Date:8/28/2012

MILLIONS) 142

FIGURE 17 QUANTITATIVE FLUORESCENCE DIAGNOSTIC TESTING MARKET FOR BREAST

CANCER, 2010–2016 ($ MILLIONS) 142

CONCLUSIONS 144

CHAPTER 9 COMPANY PROFILES 146

ABBOTT LABORATORIES 146

AETERNA ZENTARIS 147

AGENDIA 147

U.S. 147

ALTHEADX 148

AMBERGEN INC. 149

ASTRAZENECA PLC 149

ATOSSA GENETICS INC. 149

BIOTIME 150

CCC DIAGNOSTICS LLC 150

CLARINET 151

DAKO 152

DAKO NORTH AMERICA 152

EISAI INC. (HEADQUARTERS) 152

EUTROPICS PHARMACEUTICALS 153

FLUXION BIOSCIENCES 153

GENENTECH 153

GENOMIC HEALTH 154

GLAXOSMITHKLINE 154

LIFE TECHNOLOGIES 154

MDXHEALTH 155

MERCK AND COMPANY INC. 155

MYRIAD GENETICS 155

NANOSTRING TECHNOLOGIES 156

NEKTAR 156

PFIZER 156

PHIGENIX 157

RUBICON GENOMICS 157

SANOFI US 157

VENTANA MEDICAL SYSTEMS INC. 157

CHAPTER 10 DEVELOPMENTS AND COLLABORATIONS 160

CURRENT DEVELOPMENTS AND FUTURE 160

COMMERCIAL OPPORTUNITIES FOR CANCER BIOMARKER BASED DIAGNOSTIC

TESTS 160

TABLE 101 RESULTS OF A SURVEY BY MEDCO AND THE AMERICAN MEDICAL ASSOCIATION,

2009 160

BREAST CANCER DRUGS AND PATENT EXPIRY: ROCHE PROTECTS

BREAST-CANCER DRUG HERCEPTIN 161

RECENT BREAST CANCER TEST APPROVALS 161

FDA-APPROVED USE OF BREAST CANCER ASSAY ON BENCHMARK ULTRA 161

BREAST CANCER TESTS 162

ONCOTYPE DX 162

RECENT DEVELOPMENTS 163

BIOTIME: DEVELOPMENT OF THE NOVEL PAN-CANCER DIAGNOSTIC PRODUCT

PANC-DX 163

RUBICON GENOMICS AND AGENDIA PARTNER FOR DEVELOPMENT OF BREAST

CANCER DIAGNOSTICS 164

ABBOTT AND MERCK PARTNER TO EVALUATE USE OF FISH-BASED

COMPANION DIAGNOSTICS 164

ALTHEADX PARTNERING WITH COMPENDIA BIOSCIENCE 164

GE MAKES INVESTMENT I
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others
2. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Cad Software
3. Financier Jeffrey Epstein And Mount Sinai Hospital Support 3D Mammograms For Breast Cancer
4. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
5. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Volpara Breast Density Software
6. BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management
7. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
8. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
9. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
10. Breast Cancer Detection and Treatment Recovers Slowly from Big Losses During Recession
11. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 24, 2015 Boston Scientific Corporation (NYSE: BSX ... th Annual Healthcare Conference on May 6 in ... executive vice president and chief financial officer, and Susie ... 35-minute question and answer session regarding the company with the ... live webcast of the presentation and question and answer session ...
(Date:4/24/2015)... EAST HANOVER, N.J. , April 24, 2015  Novartis ... diversity for the second year in a row on the ... the results of its 2015 Top 50 Companies for Diversity ... New York, NY . NPC also ranked second on ... on the Top 10 Companies for Employee Resource Groups list. ...
(Date:4/24/2015)... /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the ... medical marijuana products and a licensed producer ("LP") to ... ( Canada ) ("MMPR"), is pleased to ... has closed the transaction announced on March 11, 2015 ... "Escrow Transfer") a total of 20,156,790 common shares of ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
... R.I., Feb. 18, 2011 CVS Caremark (NYSE: ... Management Institute (PBMI) awarded the company and its PBM ... Rx Benefit Innovation Award.  The award recognizes the Pharmacy ... manage costs, improve medication adherence and close gaps in ...
... Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a ... clearance for the TM-S Trabecular Metal™ Cervical Interbody ... interbody device incorporating porous metal technology, and the first Zimmer ... in the United States. The TM-S system is ...
Cached Medicine Technology:CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program 2CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program 3Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 2Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 3
(Date:4/25/2015)... For thirteen years, the Twin Cities DI ... event in the nation! This year, on May 5th, 2015, ... to take DI Day on the road by supporting the ... ChFC, RHU, DIA, CLTC, Chief Executive Officer at Secura Consultants ... the change by stating, "The first Twin Cities DI Day ...
(Date:4/24/2015)... California (PRWEB) April 24, 2015 Ryadon ... a wide range of capabilities and services to complement ... , Ryadon's Quantity Discount Program will be offered on ... follows: , Order 4-19: Receive 10% discount - Order ... by Using the Drawer Slides Products, ...
(Date:4/24/2015)... On February 21st, 2015, Per Wickstrom had the ... contributor Karen Salkin at Durkin Entertainment’s EcoLuxe Lounge, sponsored ... of which Wickstrom is the founder. Making appearances at ... EcoLuxe Lounge is a gathering of some of the ... and services. Among the many roles that she has ...
(Date:4/24/2015)... Integrative Therapeutics has introduced two new supplements focused ... A unique combination of herbs and nutrients, including ... apart from other antioxidant supplements. This formula relies ... versus the use of single or sequential compounds ... Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 with Setria® Glutathione. ...
(Date:4/24/2015)... National Access Cannabis (NAC), Canada’s provider ... cannabis, is taking a leadership role in ensuring Canadian ... NAC is the first to back mdBriefCase Group Inc.'s ... will be providing 300 healthcare professionals with free access ... Canadians gain safe and responsible access to medical cannabis ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2
... SOMERSET, N.J., Nov. 9 inVentiv Health Inc.,(Nasdaq: ... a new Client Development,and Integration team. The team will ... Chief Client Development Officer. The Client Development and ... segments to identify new opportunities to,serve both new and ...
... Interferon does not slow or halt the progression of ... who havent responded to previous attempts to eradicate the ... University School of Medicine participated has found. , Patients ... experience a significant decrease in viral levels and liver ...
... and techniques of soft condensed matter physics, a research team ... of attractions between proteins keeps the lens of the eye ... can cause proteins to aggregate and de-mix. This leads to ... could shed light on other protein aggregation diseases (such as ...
... after stopping the drug, researchers say , , FRIDAY, Nov. ... at a slightly increased risk for developing cervical cancer, ... very small risk disappears, a new British study suggests. ... women to continue getting screened for cervical cancer, experts ...
... 24 and Taclonex; Company ... financial guidance, ST. DAVID,S, Bermuda, Nov. 9 Warner Chilcott,Limited ... ended,September 30, 2007. Revenue in the quarter ended September 30, 2007 ... The,primary drivers of the increase in revenue were the net sales ...
... Global Commercialization, Program for Once-Daily Tramadol and Completion of Enrolment ... ... QC, Nov. 9 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) ... ended September 30, 2007. All figures are in Canadian dollars ...
Cached Medicine News:Health News:inVentiv Health Creates Client Development and Integration Team 2Health News:inVentiv Health Creates Client Development and Integration Team 3Health News:Interferon does not slow or stop hepatitis C from worsening, study finds 2Health News:Physics provides new insights on cataract formation 2Health News:Pill Poses Little Cervical Cancer Risk 2Health News:Pill Poses Little Cervical Cancer Risk 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 18Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 19Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 20Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 21Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 2Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 3Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 4Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 5Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 6Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 7Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 8Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 9Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 10
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: